Modelling the vertical distribution of bromoform in the upper water column of the tropical Atlantic Ocean

The relative importance of potential source and sink terms for bromoform (CHBr3) in the tropical Atlantic Ocean is investigated with a coupled physical-biogeochemical water column model. Bromoform production is either assumed to be linked to primary production or to phytoplankton losses; bromoform decay is treated as light dependent (photolysis), and in addition either vertically uniform, proportional to remineralisation or to nitrification. All experiments lead to the observed subsurface maximum of bromoform, corresponding to the subsurface phytoplankton biomass maximum. In the surface mixed layer, the concentration is set by entrainment from below, photolysis in the upper few meters and the outgassing to the atmosphere. The assumed bromoform production mechanism has only minor effects on the solution, but the various loss terms lead to significantly different bromoform concentrations below 200 m depth. The best agreement with observations is obtained when the bromoform decay is coupled to nitrification (parameterised by an inverse proportionality to the light field). Our model results reveal a pronounced seasonal cycle of bromoform outgassing, with a minimum in summer and a maximum in early winter, when the deepening surface mixed layer reaches down into the bromoform production laye

Comparison of carbon and opal export rates between summer and spring bloom periods in the region of the Antarctic Polar Front, SE Atlantic.

Although primary production in the Antarctic Circumpolar Current is not above the world average and carbon burial rates are low, 70% of the world's opal burial occurs in this zone and it has been suggested that blooms of large diatoms are responsible for this extraordinary situation. Here we compare export fluxes during bloom and steady-state situations near the Antarctic Polar Front in the SE Atlantic.In a previous expedition during the austral spring, we observed the development of a bloom that led to the sudden export of particles (Rutgers van der Loeff et al., 1997). Here we report the results of a second expedition to the same area in summer (Dec-Jan), 3 years later. 234Th was monitored in the surface water and in Rosette casts down to a water depth of 500m as tracer of export production in an intensive sampling program within a box of 275 x 375 km.The distribution of particulate and dissolved 234Th was remarkably constant over time and location. Total (dissolved + particulate) 234Th activities were depleted relative to its parent 238U at the surface (234Th/238U activity ratio approximately 83%), reaching equilibrium at a depth of around 190m. This constant depletion corresponds to a 234Th export rate of 1115 dpm m-2 d-1, 35% of the value observed during the spring bloom

Marine sources of bromoform in the global open ocean - global patterns and emissions

Bromoform (CHBr3) is one important precursor of atmospheric reactive bromine species that are involved in ozone depletion in the troposphere and stratosphere. In the open ocean bromoform production is linked to phytoplankton that contains the enzyme bromoperoxidase. Coastal sources of bromoform are higher than open ocean sources. However, open ocean emissions are important because the transfer of tracers into higher altitude in the air, i.e. into the ozone layer, strongly depends on the location of emissions. For example, emissions in the tropics are more rapidly transported into the upper atmosphere than emissions from higher latitudes. Global spatio-temporal features of bromoform emissions are poorly constrained. Here, a global three-dimensional ocean biogeochemistry model (MPIOM-HAMOCC) is used to simulate bromoform cycling in the ocean and emissions into the atmosphere using recently published data of global atmospheric concentrations (Ziska et al., 2013) as upper boundary conditions. Our simulated surface concentrations of CHBr3 match the observations well. Simulated global annual emissions based on monthly mean model output are lower than previous estimates, including the estimate by Ziska et al. (2013), because the gas exchange reverses when less bromoform is produced in non-blooming seasons. This is the case for higher latitudes, i.e. the polar regions and northern North Atlantic. Further model experiments show that future model studies may need to distinguish different bromoform-producing phytoplankton species and reveal that the transport of CHBr3 from the coast considerably alters open ocean bromoform concentrations, in particular in the northern sub-polar and polar regions

Numerical modelling of methyl iodide in the eastern tropical Atlantic

Methyl iodide (CH3I) is a volatile organic halogen compound that contributes significantly to the transport of iodine from the ocean to the atmosphere, where it plays an important role in tropospheric chemistry. CH3I is naturally produced and occurs in the global ocean. The processes involved in the formation of CH3I, however, are not fully understood. In fact, there is an ongoing debate whether production by phytoplankton or photochemical degradation of organic matter is the main source term. Here, both the biological and photochemical production mechanisms are considered in a biogeochemical module that is coupled to a one-dimensional water column model for the eastern tropical Atlantic. The model is able to reproduce observed subsurface maxima of CH3I concentrations. But, the dominating source process cannot be clearly identified as subsurface maxima can occur due to both direct biological and photochemical production. However, good agreement between the observed and simulated difference between surface and subsurface methyl iodide concentrations is achieved only when direct biological production is taken into account. Production rates for the biological CH3I source that were derived from published laboratory studies are shown to be inappropriate for explaining CH3I concentrations in the eastern tropical Atlantic

Methyl iodide production in the open ocean

Production pathways of the prominent volatile organic halogen compound methyl iodide (CH3I) are not fully understood. Based on observations, production of CH3I via photochemical degradation of organic material or via phytoplankton production has been proposed. Additional insights could not be gained from correlations between observed biological and environmental variables or from biogeochemical modeling to identify unambiguously the source of methyl iodide. In this study, we aim to address this question of source mechanisms with a three-dimensional global ocean general circulation model including biogeochemistry (MPIOM-HAMOCC (MPIOM - Max Planck Institute Ocean Model HAMOCC - HAMburg Ocean Carbon Cycle model)) by carrying out a series of sensitivity experiments. The simulated fields are compared with a newly available global data set. Simulated distribution patterns and emissions of CH3I differ largely for the two different production pathways. The evaluation of our model results with observations shows that, on the global scale, observed surface concentrations of CH3I can be best explained by the photochemical production pathway. Our results further emphasize that correlations between CH3I and abiotic or biotic factors do not necessarily provide meaningful insights concerning the source of origin. Overall, we find a net global annual CH3I air-sea flux that ranges between 70 and 260 Gg yr(-1). On the global scale, the ocean acts as a net source of methyl iodide for the atmosphere, though in some regions in boreal winter, fluxes are of the opposite direction (from the atmosphere to the ocean)

No severe and global X chromosome inactivation in meiotic male germline of Drosophila

This article is a response to Vibranovski et al

Implementing the European guidelines for cardiovascular disease prevention in the primary care setting in Cyprus: Lessons learned from a health care services study

<p>Abstract</p> <p>Background</p> <p>Recent guidelines recommend assessment and treatment of the overall risk for cardiovascular disease (CVD) through management of multiple risk factors in patients at high absolute risk. The aim of our study was to assess the level of cardiovascular risk in patients with known risk factors for CVD by applying the SCORE risk function and to study the implications of European guidelines on the use of treatment and goal attainment for blood pressure (BP) and lipids in the primary care of Cyprus.</p> <p>Methods</p> <p>Retrospective chart review of 1101 randomly selected patients with type 2 diabetes mellitus (DM2), or hypertension or hyperlipidemia in four primary care health centres. The SCORE risk function for high-risk regions was used to calculate 10-year risk of cardiovascular fatal event. Most recent values of BP and lipids were used to assess goal attainment to international standards. Most updated medications lists were used to compare proportions of current with recommended antihypertensive and lipid-lowering drug (LLD) users according to European guidelines.</p> <p>Results</p> <p>Implementation of the SCORE risk model labelled overall 39.7% (53.6% of men, 31.3% of women) of the study population as high risk individuals (CVD, DM2 or SCORE ≥5%). The SCORE risk chart was not applicable in 563 patients (51.1%) due to missing data in the patient records, mostly on smoking habits. The LDL-C goal was achieved in 28.6%, 19.5% and 20.9% of patients with established CVD, DM2 (no CVD) and SCORE ≥5%, respectively. BP targets were achieved in 55.4%, 5.6% and 41.9% respectively for the above groups. There was under prescription of antihypertensive drugs, LLD and aspirin for all three high risk groups.</p> <p>Conclusion</p> <p>This study demonstrated suboptimal control and under-treatment of patients with cardiovascular risk factors in the primary care in Cyprus. Improvement of documentation of clinical information in the medical records as well as GPs training for implementation and adherence to clinical practice guidelines are potential areas for further discussion and research.</p

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.

One difficulty in performing meta-analyses of observational cohort studies is that the availability of confounders may vary between cohorts, so that some cohorts provide fully adjusted analyses while others only provide partially adjusted analyses. Commonly, analyses of the association between an exposure and disease either are restricted to cohorts with full confounder information, or use all cohorts but do not fully adjust for confounding. We propose using a bivariate random-effects meta-analysis model to use information from all available cohorts while still adjusting for all the potential confounders. Our method uses both the fully adjusted and the partially adjusted estimated effects in the cohorts with full confounder information, together with an estimate of their within-cohort correlation. The method is applied to estimate the association between fibrinogen level and coronary heart disease incidence using data from 154,012 participants in 31 cohort

Prevalence of overweight and obesity in European children below the age of 10

BACKGROUND: There is a lack of common surveillance systems providing comparable figures and temporal trends of the prevalence of overweight (OW), obesity and related risk factors among European preschool and school children. Comparability of available data is limited in terms of sampling design, methodological approaches and quality assurance. The IDEFICS (Identification and prevention of Dietary-and lifestyle-induced health Effects in Children and infantS) study provides one of the largest European data sets of young children based on state-of-the-art methodology. OBJECTIVE: To assess the European distribution of weight status according to different classification systems based on body mass index (BMI) in children (2.0-9.9 years). To describe the prevalence of weight categories by region, sex, age and socioeconomic position. DESIGN: Between 2007 and 2010, 18 745 children from eight European countries participated in an extensive, highly standardised protocol including, among other measures, anthropometric examinations and parental reports on socio-demographic characteristics. RESULTS: The combined prevalence of OW/obesity ranges from more than 40% in southern Europe to less than 10% in northern Europe. Overall, the prevalence of OW was higher in girls (21.1%) as compared with boys (18.6%). The prevalence of OW shows a negative gradient with social position, with some variation of the strength and consistency of this association across Europe. Overall, population groups with low income and/or lower education levels show the highest prevalence of obesity. The use of different reference systems to classify OW results in substantial differences in prevalence estimates and can even reverse the reported difference between boys and girls. CONCLUSIONS: There is a higher prevalence of obesity in populations from southern Europe and in population groups with lower education and income levels. Our data confirm the need to develop and reinforce European public health policies to prevent early obesity and to reduce these health inequalities and regional disparities